Nephros, Inc. (NEPH)
- Previous Close
2.2200 - Open
2.3900 - Bid --
- Ask --
- Day's Range
2.2600 - 2.5500 - 52 Week Range
1.1600 - 4.0400 - Volume
60,135 - Avg. Volume
18,042 - Market Cap (intraday)
24.884M - Beta (5Y Monthly) 1.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.75
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
www.nephros.comRecent News: NEPH
Performance Overview: NEPH
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NEPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NEPH
Valuation Measures
Market Cap
24.88M
Enterprise Value
22.96M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.75
Price/Book (mrq)
3.04
Enterprise Value/Revenue
1.63
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.06%
Return on Assets (ttm)
-8.71%
Return on Equity (ttm)
-18.27%
Revenue (ttm)
14.24M
Net Income Avi to Common (ttm)
-1.57M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
4.31M
Total Debt/Equity (mrq)
21.97%
Levered Free Cash Flow (ttm)
1.65M
Research Analysis: NEPH
Company Insights: NEPH
NEPH does not have Company Insights